Market Place
Sourcing Support
All News #Library
Generics
Indian Pharma Prepares For ?600-800 Cr Insulin Pen Market
22 Sep 2025 //
BUSINESS STD
Wockhardt Exits Us Generics Biz, to Focus on Innovative Portfolio
11 Jul 2025 //
BUSINESS STD
Class Action Over Generic Clobetasol And Clomipramine
06 May 2025 //
PR NEWSWIRE
Safeguarding And Streamlining Pharma Supply Chain: Time For Certified Drugs
08 May 2020 //
FORBES
Aggrastat (tirofiban hydrochloride) : Medicure vs. Gland Pharma
24 Nov 2018 //
PATENT LITIGATION
Eliquis (Apixaban): Bristol-Myers Squibb & Pfizer v. Wockhardt
10 Apr 2017 //
PATENT LITIGATION
Fresenius Kabi wants Wockhardt to amend Zosyn approval BSE filing
30 Mar 2017 //
IN PHARMATECHNOLOGIST
Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
18 Jan 2017 //
FIERCE PHARMA
India`s Wockhardt Faces Mass Of Lawsuits In U.S. Over Generic Reglan
26 Mar 2015 //
FIERCE PHARMA ASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.